Advertisement

Topics

GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Gram-Positive and Gram-Negative Panels

22:53 EDT 29 Jun 2017 | Biotech-Finances

Thursday, June 29th 2017 at 8:30pm UTC CARLSBAD, Calif.–(BUSINESS WIRE)– GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has achieved CE Mark under the European In-Vitro Diagnostic Devices Directive (98/79/EC) for its ePlex Blood Culture Identification Gram-Positive (BCID-GP) Panel and its Blood Culture Identification Gram-Negative (BCID-GN) …

Cet article GenMark Achieves CE Mark for its ePlex® Blood Culture Identification
Gram-Positive and Gram-Negative Panels
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Gram-Positive and Gram-Negative Panels

NEXT ARTICLE

More From BioPortfolio on "GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Gram-Positive and Gram-Negative Panels"

Advertisement
Quick Search
Advertisement
Advertisement